• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of new DDS to individual organs by means of cell technology and its opplication to treatment of human diseases

Research Project

Project/Area Number 07558126
Research Category

Grant-in-Aid for Scientific Research (A)

Allocation TypeSingle-year Grants
Section試験
Research Field Biomedical engineering/Biological material science
Research InstitutionOsaka University

Principal Investigator

KANEDA Yasufumi  Division of Cellular Genetics, Institute for Molecular and Cellular Biology, Osaka University, Associate Professor, 細胞生体工学センター, 助教授 (10177537)

Co-Investigator(Kenkyū-buntansha) IMAI Enyu  1st Department of Internal Medicine, Osaka University, School of Medicine, Assis, 医学部, 助手 (00223305)
Project Period (FY) 1995 – 1996
Project Status Completed (Fiscal Year 1996)
Budget Amount *help
¥9,700,000 (Direct Cost: ¥9,700,000)
Fiscal Year 1996: ¥3,000,000 (Direct Cost: ¥3,000,000)
Fiscal Year 1995: ¥6,700,000 (Direct Cost: ¥6,700,000)
KeywordsDDS (Drug Delivery System) / Liposome / HVJ-liposome / Gene therapy / 遺伝子導入
Research Abstract

We developed a novel gene delivery vector system called HVJ-liposome. In this delivery system, DNA was entrapped into negative-charge liposome and the liposome was fused with UV-inactivated HVJ,Sendai virus, to form HVJ-liposome. HVJ-liposome is now widely used as an efficient non-viral vector for introducing DNA,oligonucleotides and proteins into various animal organs. Using this vector system, we succeeded in prevention of restenosis of balloon injured areteries of rats, suppression of glomerulosclerosis, protection of transplanted organs, and inhibition of disseminated brain tumors. However, the system should be improved for more efficient delivery system both in vitro and in vivo toward future gene therapy.
When HVJ-cationic liposome having cationic DC-cholesterol (DC-Chol) was prepared by vortexing and extrusion, the delivery of FITC-labeled antisense oligonucleotides or ribozymes was greatly enhanced, and luciferase gene expression was also increased about 70 times more than conve … More ntional HVJ-liposome containing phosphatidylserine (PS). The HVJ-DC-Chol-liposome was very useful for suicide gene therapy of disseminated glioblastoma in mouse brain. We further optimized lipid components of liposome and developed a novel HVJ-liposome consisting of sphingomyelin (Sph), dioleoylphosphatidylethanolamine (DOPE), phosphatidylcholine (PC), cholesterol (Chol) and DC-Chol (1.7 : 1.7 : 1.7 : 4.0 : 1.0 in molar ratio) as the most efficient vector for gene expression in culture cells (100-800 times higher than conventional HVJ-liposome). However, the use of cationic lipids rather reduced gene expression in animal organs, compared with conventional HVJ-liposome. Then, HVJ-liposome containing Sph, DOPE,PC,PS and Chol (1.3 : 1.3 : 1.0 : 5.0 in molar ratio) mimicking HIV envelope (called HVJ-AVE liposome) raised gene expression in either liver or muscle 5-10 times more than conventional HVJ-liposome. Thus, cationic lipids appeared to have reciprocal effects in gene expression in vitro and in vivo, and our finding indicates the alternative usage of liposomes for in vitro and in vivo gene transfer. Less

Report

(3 results)
  • 1996 Annual Research Report   Final Research Report Summary
  • 1995 Annual Research Report
  • Research Products

    (30 results)

All Other

All Publications (30 results)

  • [Publications] Tomita, N. & Kaneda, Y.: "In vivo gene transfer of insulin gene into neonatal rats by HVJ-liposome method resulted in sustained transgene expression." Gene Therapy. 3. 477-482 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Akagi, S.: "In vivo transfection of antisense oligodeocynucleotides for TGF-β1 into the kidney suppressed glomerulosclerosis and induction of a-smooth muscle actin in experimental glomerulonephritis." Kidney Inter.50. 148-155 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Isaka, Y.: "Decorin gene tranfer into skeletal muscle blocks fibrinogenesis in the kidney." Natute Medicine. 2. 418-423 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Nakamura, N.: "Transient introduction of a foreign gene into healing rat patellar ligament." J. Clin. Invest.97. 226-231 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Hayashi, S.: "Skin-specific in vivo gene and oligonucleotides transfer into fetal rats as novel model of tissue-specific overexpression of transgene or knock-out by antisense oligonucleotides." Gene Therapy. 3. 878-885 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Dzau, V. J., & Kaneda, Y.: "Fusigenic viral liposome for gene therapy in cardiovascular diseases." Proc. Natl. Acad. Sci. (USA). 93. 11421-11425 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Kaneda, Y.: "Bone Marrow Transplantation." Springer-Verlag, Tokyo, 331 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Kaneda, Y.: "The Foueth SaratogaInternational Conference on Atherosclerosis" The New York Academy of Sciences (in press),

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Tomita, N.& Kaneda, Y.: "Invivo gene transfer of insulin gene into neonatal rats by HVJ-liposome method resulted in sustained transgene expression." Gene Therapy. 3. 477-482 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Akagi, S.: "In vivo transfection of antisense oligodeoxynucleotides for TGF-beta1 into the kidney suppressed glomerulosclerosis and induction of a-smooth muscle action in experimental glomerulonephritis." Kidney Inter.50. 148-155 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Isaka, Y.: "Decorin gene transfer into skeletal muscle blocks fibrinogenesis in the kidney." Nature Medicine. 2. 418-423 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Nakamura, N.: "Transient introduction of a foreign gene into healing rat patellar ligament." J.Clin.Invest.97. 226-231 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Hayashi, S.: "Skin-specific in vivo gene and oligonucleotides transfer into fetal rats as novel model of tissue-specific overexpression of transgene or knock-out antisense oligonucleotides." Gene Therapy. 3. 878-885 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Dzau, V.J.& Kaneda, Y.: "Fusigenic viral loposome for gene therapy in cardiovascular diseases." PNAS,USA,93. 11421-11425 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Tomita,N.& Kaneda,Y.: "In vivo gene transfer of insulin gene into neonatal rats by HVJ-liposome method resulted in sustained transgene expression." Gene Therapy. 3. 477-482 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] Akagi,S.: "In vivo transfection of antisense oligodeoxynucleotides for TGF-β1 into the kidney suppressed glomerulosclerosis and induction of a-smooth muscle actin in experimental glomerulonephritis." Kidney Inter.50. 148-155 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] Isaka,Y.: "Decorin gene transfer into skeletal muscle blocks fibrinogenesis in the kidney." Natute Medicine. 2. 418-423 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] Nakamura,N.: "Transient introduction of a foreign gene into healing rat patellar ligament." J.Clin.Invest.97. 226-231 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] Hayashi,S.: "Skin-specific in vivo gene and oligonucleotides transfer into fetal rats as novel model of tissue-specific overexpression of transgene or knock-out by antisense oligonucleotides." Gene Therapy. 3. 878-885 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] Dzau,V.J.,& Kaneda,Y.: "Fusigenic viral liposome for gene therapy in cardiovascular diseases." Proc.Natl.Acad.Sci. (USA). 93. 11421-11425 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] Kaneda,Y.: "Bone Marrow Transplantation." Springer-Verlag,Tokyo, 331 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] Kaneda,Y.: "The Fourth Saratoga International Conference on Atherosclerosis" The New York Academy of Sciences (in press),

    • Related Report
      1996 Annual Research Report
  • [Publications] Kaneda,Y.: "Increased expression of DNA cointroduced with nuclear protein in adult rat liver." J.Mol.Med.73. 289-297 (1995)

    • Related Report
      1995 Annual Research Report
  • [Publications] Mann,M.: "Genetic engineering of vein grafts resistant to atherosclerosis." Proc.Natl.Acad.Sci.(USA). 92. 4502-4506 (1995)

    • Related Report
      1995 Annual Research Report
  • [Publications] Leyen,H.E.: "In vivo transfer of endothelial cell nitric oxide synthase gene." Proc.Natl.Acad.Sci.(USA). 92. 1137-1141 (1995)

    • Related Report
      1995 Annual Research Report
  • [Publications] Morishita,R.: "A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo." Proc.Natl.Acad.Sci.(USA). 92. 5855-5859 (1995)

    • Related Report
      1995 Annual Research Report
  • [Publications] Tomita,N.: "Transient decrease in high blood pressure by in vivo transfer of antisense oligodeoxynucleotides against rat angiotensinogen." Hypertension. 26. 131-136 (1995)

    • Related Report
      1995 Annual Research Report
  • [Publications] Yoshida,M.: "Histologically distinctive interstitial pneumonia induced by overexpression of IL-6,TGF beta,or PDGF gene." Proc.Natl.Acad.Sci(USA). 92. 9570^9574 (1995)

    • Related Report
      1995 Annual Research Report
  • [Publications] Kaneda,Y.: "Cold Spring Harbor Symp.Quant.Biol." Cold Spring Harbor Laboratory Press, (In press) (1995)

    • Related Report
      1995 Annual Research Report
  • [Publications] Yanagihara,I.: "Molecular and Cell Biology of Human Gene Therapeutics" Chapmann & Hall,London, 403 (1995)

    • Related Report
      1995 Annual Research Report

URL: 

Published: 1995-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi